Jae-Kwan Cha Selected Research

Adenosine Diphosphate (ADP)

7/2016	High residual platelet reactivity (HRPR) for adenosine diphosphate (ADP) stimuli is a determinant factor for long-term outcomes in acute ischemic stroke with anti-platelet agents: The meaning of HRPR after ADP might be more prominent in large atherosclerotic infarction than other subtypes of AIS.
3/2014	Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
6/2008	Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Kwan Cha Research Topics

Disease

61	Stroke (Strokes) 05/2024 - 10/2002
57	Ischemic Stroke 05/2024 - 10/2002
16	Atrial Fibrillation 04/2024 - 03/2014
12	Atherosclerosis 03/2024 - 01/2003
10	Infarction (Infarctions) 11/2021 - 01/2009
6	Embolic Stroke 11/2021 - 01/2010
4	Hemorrhagic Stroke 01/2023 - 01/2010
4	Thrombosis (Thrombus) 11/2021 - 10/2002
3	Myocardial Infarction 05/2024 - 01/2019
3	Hypertension (High Blood Pressure) 02/2023 - 01/2021
3	Cognitive Dysfunction 01/2023 - 05/2018
3	Transient Ischemic Attack 01/2022 - 01/2019
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2019 - 09/2016
2	Hemorrhage 01/2023 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 12/2014
2	Cerebral Infarction 11/2021 - 06/2014
2	Pathologic Constriction (Stenosis) 11/2019 - 06/2008
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 11/2015 - 01/2003
2	Carotid Stenosis (Carotid Artery Stenosis) 06/2008 - 01/2003
1	Hyperglycemia 02/2023
1	Hypothermia 02/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Blood Vessel Dissection 01/2022
1	Neoplasms (Cancer) 01/2022
1	Headache (Headaches) 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 11/2021
1	Frailty 12/2020
1	Leukocytosis (Pleocytosis) 10/2020
1	Cerebral Hemorrhage 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 06/2017
1	Intracranial Embolism 01/2017
1	Constipation 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Myalgia 01/2017
1	Inflammation (Inflammations) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Ischemia 07/2015
1	Diabetes Mellitus 12/2014

Drug/Important Bio-Agent (IBA)

16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 10/2002
13	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2019 - 09/2010
10	Clopidogrel (Plavix)FDA Link 05/2024 - 10/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 08/2004
8	AnticoagulantsIBA 04/2024 - 01/2018
6	Escitalopram FDA Link 11/2021 - 01/2017
6	P-SelectinIBA 12/2008 - 10/2002
5	LDL CholesterolIBA 11/2023 - 01/2016
5	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 12/2008
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 11/2019
4	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2016
4	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2014
3	oxidized low density lipoproteinIBA 09/2023 - 09/2022
3	LipidsIBA 09/2023 - 01/2016
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 12/2008
3	Adenosine Diphosphate (ADP)IBA 07/2016 - 06/2008
3	C-Reactive ProteinIBA 01/2016 - 10/2002
2	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 11/2021 - 01/2018
2	Probucol (Lorelco)FDA Link 01/2021 - 01/2020
2	Calcibiotic Root Canal SealerIBA 01/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 10/2002
2	CholesterolIBA 11/2015 - 12/2014
1	Factor Xa (Coagulation Factor Xa)IBA 04/2024
1	edoxabanIBA 05/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023
1	oxiracetamIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2022
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	pro-brain natriuretic peptide (1-76)IBA 08/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	A-factor (Streptomyces)IBA 10/2020
1	Ezetimibe (Zetia)FDA Link 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Vitamin K FDA Link 01/2018
1	N(4)-oleylcytosine arabinosideIBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 10/2017
1	RivaroxabanIBA 10/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	Particulate MatterIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 11/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2015

Therapy/Procedure

26	Therapeutics 05/2024 - 08/2004
6	Thrombolytic Therapy 03/2018 - 01/2010
5	Thrombectomy 02/2023 - 01/2017
4	Secondary Prevention 05/2024 - 01/2022
2	Treatment Delay 11/2019 - 05/2016
2	Cerebral Revascularization 06/2018 - 10/2017
1	Ambulatory Care (Outpatient Care) 01/2021
1	Cardiopulmonary Resuscitation (CPR) 01/2016
1	Stents 05/2015